The endotoxins of gram-negative bacteria in minute amounts elicit an array of characteristic physiological alterations in mammals including such diverse phenomena as production of fever (1, 3) , stimulation of resistance to infection (12, 21, 29) , and protection against radiation injury (26) . Higher dosage induces a state of stress, acute shock, or eventual death. In tumorbearing animals, extensive intratumoral hemorrhage is associated with necrotization of the malignant tissue (25) . In the present paper the occurrence of a possible metabolic common denominator in this wide range of phenomena will be considered.
Previous work (10, 31, 32) has demonstrated an insulin :anti-insulin hormonal mechanism that regulates the rate of glycolysis in certain tumors and normal tissues. Three years ago, as the result of metabolic studies in vitro in a series of experimental tumors, we observed that endotoxins exerted a stimulatory effect on cell glycolysis remarkably similar to the action of insulin (33) . Endotoxin in concentrations of 0.003 to 0.3 Ag per ml stimulated the formation of acid aerobically from glucose as much as severalfold; at the same time, oxygen uptake remained essentially unaffected. Anaerobic glycolysis was stimulated to a lesser extent.
In certain tumors, glycolysis and growth are inhibited by a state of stress in the host (10, 31) . This glycolytic inhibition, which apparently involves steroid action, is reversed in vitro by insulin. In such tumors, endotoxin was found to exert an effect remarkably similar to that of insulin (33, 34) . Since insulin stimulation often masked glycolytic stimulation by endotoxin, a 1 This symposium was held at the Annual Meeting of the American Society for Microbiology in Chicago, Ill., 24 April 1961 , under the sponsorship of the Division of Medical Bacteriology and Immunology with Maurice Landy as convener. 2 Present address: Queen Elizabeth Hospital, Birmingham, England. common locus of action was suggested. Moreover, glycolysis in tumors not sensitive to stress, or to insulin, remained unaffected by endotoxin.
We were particularly impressed by the fact that the degree of stimulation of tumor glycolysis observed in vitro with a series of endotoxin preparations paralleled their potencies in eliciting endotoxic phenomena in vivo (33) . Furthermore, reduction in the host-reactive properties of endotoxin by an enzyme system present in normal serum (13) , or in liver homogenate (28) , was paralleled by a similar decrease in its effect on glycolysis (33) . These, and other findings, led us to postulate that the properties required for elicitation of reactions in the host by such macromolecular materials were the same as those involved in influencing glycolysis in vitro. It appeared likely, as we had previously shown for insulin, that these glycolytic effects of endotoxin resulted from a specific counteraction of the endogenous, stress-modifiable inhibitor mechanism that controls glucose metabolism.
The tumors employed in these studies have proved to be unusually favorable tools for studying the metabolic actions of endotoxin and insulin. The phenomena observed, however, are by no means unique for malignant tissues. Cohn and Morse (4-6) reported glycolytic stimulation, without respiratory impairment, with rabbit polymorphonuclear leukocytes. Of great importance was the fact that they correlated this glycolytic stimulation with an enhancement of phagocytic capacity, a phenomenon already shown by Sbarra and Karnovsky (19, 20) and Karnovsky and Sbarra (11) to be dependent on glycolysis. Cohn and Morse (5, 6) pointed out that it was not possible to decide from their experiments whether the endotoxin-induced stimulation of leukocyte glycolysis was an expression of increased membrane permeability or a direct enzymatic interaction. Yunis and Harrington (35) (14) reported acceleration of glycolysis in leukocytes following exposure to bacterial pyrogens. However, he attributed this effect to a diminution of oxygen consumption and suggested that the observed alteration in respiratory function occurred in the cyclophorase system. Later, Martin et al. (15, 16) noted that insulin in vitro increased lactate production in leukocytes of diabetic subjects and that glycolysis of leukocytes was increased by low concentrations (0.03 ug per ml) of Pyromen (endotoxin from Pseudomonas aeruginosa).
Hochstein (8, 9) has shown in mitochondrial preparations of mouse melanoma that the inhibitory effects of sex steroids, or the stimulatory effects of insulin on glycolysis, are eliminated by supplying glucose 6-phosphate instead of glucose as substrate, thereby demonstrating a localization of the effects of these hormones at the hexokinase reaction. Recently, Giger (7) has obtained similar stimulation of glycolysis in mitochondrial preparations of melanoma and of brain with endotoxin and insulin.
There are many reports dealing with the stimulatory effects of bacterial lipopolysaccharides on the chemotactic or phagocytic capacities of leukocytes (2, 22, 27) . Schar and Meier (24) have recently shown that endotoxin-induced stimulation of migration in vitro of leukocytes is glucose dependent, and is counteracted by cortisone (23). Snell (27) loss in glycolytic potency generally paralleled the loss in biological activity as shown by the increase in the amount required for a 50% lethal effect in mice. Table 2 shows that when endotoxin was acted upon by host enzymes in human plasma (13) , or in rabbit liver homogenate (28), the glycolysis-stimulating capacity of the polysaccharide was destroyed. This coincided with a loss of biological potency in vivo.
These and other results made it clear that there is a close correlation between glycolysis-stimulating activity in vitro and biological properties in vivo of products that ranged from the most highly purified endotoxins to weakly active materials such as lipid A.
TUMOR SPECTRUM SHOWING GRADED
GLYCOLYTIC RESPONSES TO ENDOTOXIN The qualitative similarities between the action of endotoxin and insulin on glycolysis were shown in still other ways. Tumors could be arranged in a "spectrum" according to their sensitivity to glycolytic inhibition by certain steroids, or, conversely, to stimulation by insulin (Table 3) . When endotoxin and insulin were compared in such a spectrum of tumors, it was evident that the largest responses to endotoxin, or to insulin, occurred in tissues most sensitive to inhibiton by steroid, in this instance testosterone.3
Under ordinary conditions, glycolysis in K-2 carcinoma was practically insensitive to the effects of host stress in vivo, or to steroids in vitro (10, 31, 32) . Consequently, as expected, this tumor showed little or no direct response to insulin or endotoxin. It is probable that the same insulin: anti-insulin mechanism regulates glucose metabolism in most mammalian tissues. However, the degree of glycolytic sensitivity to inhibition of this mechanism varies considerably in different tissues. In melanoma, saturating levels of insulin were somewhat more effective than saturating levels of endotoxin in stimulating aerobic glycolysis. Under anaerobic conditions this differential was magnified. 
ENDOTOXIN ACTION ON LEUKOCYTES
In tissues where myeloid elements predominate, such as rabbit bone marrow, rabbit peritoneal exudates, and human myelogenous leukemias, the stimulating action of endotoxin usually exceeded that of insulin (Fig. 2) . In lymphatic leukemia, however, insulin generally stimulated glycolysis to a greater extent than did endotoxin (Fig. 3) . Aerobic glycolysis in lymphatic leukemia was accentuated by the use of Krebs-Ringer medium (Fig. 3) . In serum there was little aerobic glycolysis in lymphocytic. cells. Considerable variation in absolute metabolic rates and effects was encountered depending on the particular conditions. These differences were probably quantitative rather than qualitative. They may, however, have an important bearing on responses in vivo to endotoxin in such tissues Measurements of intracellular levels of high energy phosphate (adenosine diphosphate plus adenosine triphosphate) by Joseph Seitz in our laboratory, showed that such levels were increased in melanoma slices incubated aerobically with either endotoxin or insulin. These results indicate that in this tumor endotoxin does not directly produce uncoupling or other damage to the energy metabolism of the cell. This view is further supported by the data in Fig. 4 where it can be seen that the stimulation of glycolysis in melanoma was not masked by the presence of the uncoupling agent 2,4-dinitrophenol (2,4-DNP). An endotoxin-insensitive tumor, the K-2 carcinoma, responded to 2,4-DNP, but not to endotoxin. Other experiments showed that insulintreated melanoma tissue reacted to 2,4-DNP in the same way, although the stimulation with insulin was somewhat greater than with endotoxin. These results are consistent with the concept that in the "uncoupled" melanoma cells the insulin-and endotoxin-sensitive hexokinase reaction is still a rate-limiting step for glycolysis. As this is not always the case in vivo. When endotoxin was administered intravenously to mice bearing melanoma, an intitial glycolytic stimulation (as measured in vitro) took place (Fig. 5) . In this case, glycolysis of the melanoma was above control levels within 10 min after intravenous injection of 20 .cg of Serratia marcescens endotoxin. This was observed under both aerobic and anaerobic conditions. Respiration was not affected significantly. Further addition of endotoxin in vitro produced additional glycolytic stimulation. However, in other S91 tumors both respiration and glycolysis were below normal levels 26 hr after intravenous injection of endotoxin. Further addition of endotoxin stimulated glycolysis but not respiration. There was considerable variation in response of melanoma to endotoxin in vivo. However, in the absence of visible hemorrhage and necrosis a biphasic stimulation of glycolysis occurred. Thus, for example, 43 hr after injection of endotoxin, glycolytic rates were found to be slightly above control levels. 
B. Mouse Peritoneal Macrophages
In mice given endotoxin, biphasic glycolytic responses were clearly apparent in peritoneal macrophages. Whitby et al. (30) have described these effects in relation to changes in nonspecific resistance to infection. Figure 6 shows the effects obtained with 5 (from Salmonella enteritidis) on anaerobic glycolysis of mouse peritoneal macrophages Endotoxin was given at the indicated dosages and glycolytic measurements in vitro were made after the indicated time periods. Krebs-Ringer solution plus 0.3% sodium bicarbonate and 0.3% glucose. Gas phase 95% N2 plus 5% CO2 at 37 C. macrophages were washed out of successive groups of animals at the time periods indicated in the figure. Sixty minutes after injection, anaerobic glycolysis was slightly higher than in control cells where endotoxin was supplied in vitro only. Following the initial stimulation, glycolytic rates declined to levels below the control without endotoxin. Thereafter, a secondary rise occurred in cells from endotoxin-injected mice, and 24 hr after injection glycolytic rates were considerably above the initial level of stimulation.
In another experiment, 50 ,g of endotoxin were injected intravenously; 9 hr after injection glycolysis was 57% below the control rate, at 16 hr after injection the inhibition was only 27%, at 72 hr the rate was 16% above normal, and at 96 hr it was 52% above the normal level. The glycolytic rate was still 52% above the control level at 6 and also 8 However, secondary inhibition of glycolysis in spleen was rapidly followed by a marked secondarv rise that was maximal about 42 hr after injection, and by 72 hr the glycolytic rate had almost returned to control levels.
Analysis of the experiments with tumor, macrophage, and spleen cells suggested that at least three separate, although interacting, processes are involved in producing these complex biphasic syndromes. An initial glycolytic stimulation (as measured in vitro) follows administration in vivo of endotoxin. However, when the level of injected endotoxin is sufficiently high, a state of general stress is produced in the host and the tissues are subjected to stress-accentuated glycolytic inhibition. Injection of endotoxin results in an increase in the level of ketosteroids in the circulation [Nadel et al. (17) ]. Glycolytic inhibition is sufficient to overcome not only the initial endotoxin-induced stimulation, but also to lower the rate below endogenous control levels. Glycolytic stimulation is once again evident as the effects of the initial stress diminish. In a sense this is like a persistent insulin action that cannot be fully compensated for by the usual anti-insulin hormonal, or other control mechanisms.
D. Endotoxin-insensitive Tumors Experiments with K-2 carcinoma made possible a clear-cut separation of the reversible glycolytic inhibitory effects of endotoxin-induced host stress from the irreversible injury resulting from endotoxin-induced damage to the blood vessels. Glycolysis in the K-2 carcinoma, in either solid or ascitic forms, is practically insensitive to inhibition by steroids, and host stress in vivo thus has no significant effect on its glycolysis (10, 31, 32 glycolysis (Fig. 7) , indicative of extensive cell destruction. However, when the tumor was in the ascitic form, and thus relatively independent of the effects of host vascular impairment, a very different result was obtained. Injections of 200 ,ug of endotoxin directly into the peritoneal cavity did not significantly alter glycolytic or respiratory rates of the tumor cells (Fig. 8) 
